Picture of Kobayashi Pharmaceutical logo

4967 — Kobayashi Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeLarge CapHigh Flyer

Table: Kobayashi Pharmaceutical -2016 group results

Feb 1 (Reuters)-  
          Kobayashi Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Dec 31, 2016    Mar 31, 2016   Dec 31, 2017     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales            120.05          137.21         150.00        63.50     
                                 (+6.9 pct)                               
  Operating         17.41           18.26          20.00         7.60     
                                 (+1.9 pct)                               
  Recurring         19.50           17.95          21.00         7.10     
                                 (-4.7 pct)                               
  Net 
  Net               14.32           13.47          15.10         5.00     
                                 (+8.2 pct)                               
  EPS            179.12 yen      165.56 yen     191.64 yen    63.46 yen   
  EPS Diluted    178.86 yen      165.30 yen                               
  Ann Div         52.00 yen       96.00 yen      52.00 yen                
  -Q2 Div         25.00 yen       48.00 yen      26.00 yen                
  -Q4 Div         27.00 yen       48.00 yen      26.00 yen                
   
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Kobayashi Pharmaceutical

See all news